1-4 of 4
Kay Decker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation

Roy Khalife, Lindsay Cowley, Alan T. Tinmouth, Lisa D. Duffett, Vanessa Bourck, Alfonso Iorio, Davide Matino, Kay Decker, Karen Strike, David Page, Natasha Pardy, Jerome M. Teitel, Haowei Linda Sun
Journal: Blood
Blood (2024) 144 (Supplement 1): 3634.
https://doi.org/10.1182/blood-2024-198579
Published: 2024
Journal Articles

Patient and Clinical Experience on Concizumab Clinical Trial: A Case Study

Karen Strike, Mihir Bhatt, Nessa Chan, Nasrin Samji, Kay Decker, Rebecca Goldsmith, Anthony K C Chan
Journal: Blood
Blood (2024) 144 (Supplement 1): 5494.
https://doi.org/10.1182/blood-2024-209470
Published: 2024
Journal Articles

Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate ® ) in Patients with Von Willebrand Disease

Hassan M. Yaish, MD, Maria Sol Cruz, MD, Kay Decker, Eva M.K. Zetterberg, MD PhD, Sylvia Werner, Mariko Hashimoto, Sigurd Knaub, George M. Rodgers, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1182.
https://doi.org/10.1182/blood-2018-99-118069
Published: 2018
Journal Articles

Undetected Factor VIII Level in a Type III von Willebrand Disease (vWD) Patient Masquerading as Severe Hemophilia A.

Ali M. Mullah-Ali, MD, Anthony Chan, MBBS, Mohan K. Pai, MD, Kay Decker, RN, Karen A. Moffat, ART, Irwin Walker, MD
Journal: Blood
Blood (2005) 106 (11): 4095.
https://doi.org/10.1182/blood.V106.11.4095.4095
Published: 2005